About Merck
Merck is a company based in Kenilworth (United Kingdom) founded in 1891. It operates as a Direct-to-Consumer (D2C) and Professional Services. The company has 781 employees as of December 31, 2023. Merck has completed 33 acquisitions, including Abceutics, Acceleron Pharma and Afferent Pharmaceuticals. Merck offers products and services including Medicines and Vaccines and Animal Health Products. Merck operates in a competitive market with competitors including Roivant Sciences, AbbVie, Gilead, Lilly and Vertex Pharmaceuticals, among others.
- Headquarter Kenilworth, United Kingdom
- Employees 781 as on 31 Dec, 2023
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Merck & Co., Inc.
-
Annual Revenue
$65.01 B (USD)1.62as on Dec 31, 2025
-
Net Profit
$18.25 B (USD)6.64as on Dec 31, 2025
-
EBITDA
$19.94 B (USD)-51as on Dec 31, 2024
-
Latest Funding Round
$167 K (USD), Grant
Sep 15, 2021
-
Investors
Gates Foundation
& 2 more
-
Employee Count
781
as on Dec 31, 2023
-
Investments & Acquisitions
Abceutics
& 32 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Merck
Merck offers a comprehensive portfolio of products and services, including Medicines and Vaccines and Animal Health Products.
Medicines and vaccines are developed for various diseases.
Products for animal health are provided globally by Merck.
People of Merck
Unlock access to complete
Unlock access to complete
Leadership Team
442 people
Software Development Team
251 people
Product Management Team
73 people
Sales and Marketing
73 people
Senior Team
64 people
Data Analysis and Operations Team
63 people
Operations Team
54 people
Finance and Accounting
30 people
Unlock access to complete
Funding Insights of Merck
Investors in Merck
Merck has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Gates Foundation, HHS and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Charitable foundation investments on poverty reduction and healthcare
|
Locked | Locked | Locked |
Investor details for Merck
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Merck
Merck has strategically engaged in corporate development activities, having acquired 33 companies. Notable acquisitions include Abceutics, Acceleron Pharma and Afferent Pharmaceuticals.
Investment portfolio details for Merck
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developer of therapeutics for the treatment of cancer
|
Locked | Locked | 2021 | Locked | |
|
Antibody-drug conjugates for cancer treatment are enhanced by Abceutics.
|
Locked | Locked | 2020 | Locked | |
|
Neurodegenerative disease treatments are developed using stem cell-derived neurons.
|
Locked | Locked | 2018 | Locked |
Complete acquisition details for Merck
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Merck
Detailed financials for Merck
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Merck Comparisons
Peer comparison for Merck
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Merck
Merck operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Roivant Sciences, AbbVie, Gilead, Lilly and Vertex Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| Locked | Locked | Locked |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
|
| Locked | Locked | Locked |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| Locked | Locked | Locked |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| Locked | Locked | Locked |
Developer of drugs for the treatment of multiple disorders
|
Detailed competitors of Merck
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Merck
Complete news archive for Merck
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Merck
Merck was founded in 1891 and raised its 1st funding round 120 years after it was founded.
Merck is headquartered in Kenilworth, United Kingdom. It is registered at Kenilworth, Warwickshire, United Kingdom.
Robert M Davis is the current CEO of Merck.
As of Dec 31, 2023, the latest employee count at Merck is 781.
Annual revenue of Merck is $65.01B as on Dec 31, 2025.
Merck is established as a premier biopharmaceutical company focused on research and development. The company is engaged in creating innovative medicines and vaccines across various therapeutic areas including oncology, infectious diseases, and cardio-metabolic disorders. Solutions are developed through advanced data science, artificial intelligence, and sustainable science practices. Operations are conducted with a commitment to sustainability, aiming to benefit global communities. The animal health division is also managed, providing products for veterinary care worldwide.
Merck's top competitors include Roivant Sciences, AbbVie and Lilly.
Merck offers Medicines and Vaccines and Animal Health Products.
Merck has made 33 acquisitions, including Abceutics, Acceleron Pharma, and Afferent Pharmaceuticals.
Merck has 3 investors. Key investors include Gates Foundation, HHS, and European Union.